Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 329 publications
Association Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use and All-Cause Mortality in Patients With Pulmonary Arterial Hypertension.
Journal: Cureus
Published: August 05, 2025
Fournier's Gangrene Associated With Ertugliflozin.
Journal: Journal of pharmacy practice
Published: July 28, 2025
Liquid chromatography-tandem mass spectrometry method for quantification of ertugliflozin in human plasma: Application to disposition kinetics.
Journal: European journal of mass spectrometry (Chichester, England)
Published: July 15, 2025
Post-marketing safety profile of Ertugliflozin: Insights from a real-world pharmacovigilance analysis based on the FAERS database.
Journal: European journal of pharmacology
Published: June 22, 2025
The Role of Diabetes and SGLT2 Inhibitors in Cerebrovascular Diseases.
Journal: Current neurology and neuroscience reports
Published: May 08, 2025
Revealing water structure modification by a sodium-glucose cotransporter-2 inhibitor-type antidiabetic drug with D-(+)-glucose in aqueous media.
Journal: Physical chemistry chemical physics : PCCP
Published: May 06, 2025
SGLT2 inhibitors Use in Kidney Disease: What Did We Learn?
Journal: American journal of physiology. Endocrinology and metabolism
Published: April 25, 2025
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now.
Journal: Cells
Published: April 13, 2025
Molecular interactions of diabetes medications with alzheimer's related targets by molecular docking.
Journal: Journal of diabetes and metabolic disorders
Published: April 13, 2025
Last Updated: 10/31/2025